Implantable Pulmonary Artery Sensors: What Nurses Need to Know

Author(s): Velasco Juvel-Lou P

Contact Hours 1.20

CERP A 1.20

Expires Dec 31, 2026

Topics: Hemodynamics, Technology

Population: Adult

Role: Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

The implantable pulmonary artery (PAP) sensor represents an innovative technology that enables healthcare providers to directly and remotely monitor intracardiac pressures. There is a growing body of evidence supporting the efficacy of pulmonary artery pressure sensor devices in preventing and reducing heart failure readmissions. As of January 2021, more 20,000 patients have received this implantable device. With the recent approval from the Food and Drug Administration to expand the device’s indications in March 2022, it is anticipated that the rate of implantation will double. Therefore, it is crucial for nurses to gain expertise in caring for patients implanted with this device.

Objectives

  • Review normal intracardiac pressures and their surrogate values.
  • Identify the criteria for eligibility for implantable pulmonary artery pressure sensors.
  • Describe the care involved during the screening phase, the implantation phase and the optimization/maintenance phase.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.